About Glimisave MV 3.3 Tablet
Glimisave MV 3.3 Tablet 10’s is a combination of anti-diabetic drugs used to treat type 2 diabetes mellites. Type 2 diabetes is a chronic or lifelong condition that affects the way your body processes glucose. People with type 2 diabetes either do not produce enough insulin or if at all the insulin is produced, it is unable to perform its function in the body (insulin resistance). Due to this, the blood glucose level increases and causes symptoms such as frequent urination, increased thirst and increased hunger start.
Glimisave MV3.3 Tablet 10’s is a combination of three antidiabetic drugs: Glimepiride, Metformin and Voglibose. Glimepiride, which is a ‘sulfonylurea’, acts by increasing the amount of insulin released by the pancreas. Metformin, which is a ‘biguanide’, acts by lowering the glucose production in the liver, delaying glucose absorption from the intestines and increasing the body’s response to insulin. Voglibose, which is an ‘alpha-glucosidase inhibitor’, prevents the breakdown of complex sugars into simple sugars such as glucose in the intestine. In a nutshell, the three medicines together prevent the blood glucose levels from rising to very high levels, thus keeping your diabetes under control.
Glimisave MV 3.3 Tablet 10’s should be taken with food to avoid an upset stomach. Based on your medical condition, your doctor will decide for how long you need to take Glimisave MV 3.3 Tablet 10’s. Glimisave MV3.3 Tablet 10’s may cause certain common side effects such as hypoglycaemia (low blood glucose levels), taste change, nausea, diarrhoea, stomach pain, headache, upper respiratory symptoms. Most of these side effects do not require medical attention and will resolve gradually over time. However, if you experience these side effects persistently, consult your doctor.
Continue taking Glimisave MV 3.3 Tablet 10’s for as long as your doctor has advised. If you stop taking Glimisave MV 3.3 Tablet 10’s abruptly, it may increase your sugar levels which could further increase the risk of eyesight loss (retinopathy), kidney (nephropathy) and nerve damage (neuropathy). Glimisave MV 3.3 Tablet 10’s should not be taken if you have type 1 diabetes mellitus, severe kidney or liver disease. Please inform your doctor if you have any type of heart disease, are planning to get pregnant or are breastfeeding.
Uses of Glimisave MV 3.3 Tablet 10’s
Type 2 diabetes mellitus
Medicinal Benefits
Glimisave MV3.3 Tablet 10’s contains Glimepiride, Metformin and Voglibose. Glimepiride, which is a ‘sulfonylurea’, acts by increasing the amount of insulin released by the pancreas. Metformin, which is a ‘biguanide’, acts by lowering the glucose production in the liver, delaying glucose absorption from the intestines and increasing the body’s response to insulin. Voglibose, which is an ‘alpha-glucosidase inhibitor’ prevents the breakdown of complex sugars into simple sugars such as glucose in the intestine. Glimisave MV3.3 Tablet 10’s prevents the blood glucose levels from rising to very high levels thus keeping your diabetes under control. Glimisave MV 3.3 Tablet 10’s also helps to prevent serious complications of diabetes such as kidney damage (Diabetic Nephropathy), blindness (Diabetic Retinopathy), loss of sensation in your hands and feet (Diabetic Neuropathy), Glimisave MV3.3 Tablet 10’s also helps to reduce your chance of having a heart attack or stroke. Being a combination of three drugs, Glimisave MV 3.3 Tablet 10’s reduces the need to take multiple pills and hence makes it easier to remember to take the drugs.
Related Product
Glimisave 1mg Tablet
Glimisave 2 mg Tablet
Glimisave 4mg Tablet
Glimisave M1 Tablet
Glimisave M2 Tablet
Glimisave M3 Tablet
Glimisave M1 750mg Tablet
Glimisave M1 850mg Tablet
Glimisave M1 Forte Tablet
Glimisave M2 750mg Tablet
Glimisave M2 850mg Tablet
Glimisave M2 Forte Tablet
Glimisave M3 Forte Tablet
Glimisave M4 Forte Tablet
Glimisave Max 2 Tablet
Glimisave Max 3 Tablet
Glimisave Max Forte 1 Tablet
Glimisave Max Forte 2mg Tablet
GlimiSave Max Forte 3mg Tablet
Glimisave MV 1 Tablet
Glimisave MV 2 Tablet
Glimisave MV 2.2F Tablet
Glimisave MV 2.3 Tablet
Glimisave MV 3.3 Tablet
Glimisave MV2 Forte Tablet
Directions for Use
Storage
Side Effects of Glimisave MV 3.3 Tablet 10’s
- Hypoglycaemia (low blood glucose level)
- Taste change
- Nausea
- Diarrhoea
- Stomach pain
- Flatulence
- Headache
- Upper respiratory symptoms
In-Depth Precautions and Warning
Drug Warnings
Some diabetic patients taking Glimisave MV 3.3 Tablet 10’s may develop a rare but serious condition called lactic acidosis. In this condition, there is too much lactic acid accumulated in the blood. So, your liver and kidney proper functioning is required for the elimination of excess lactic acid from the blood. You should not take Glimisave MV3.3 Tablet 10’s if you have kidney disease, as measured by a blood test. Glimisave MV 3.3 Tablet 10’s may lower vitamin B12 levels, so try to have blood test annual blood and vitamin. Glimisave MV3.3 Tablet 10’s when used with or without insulin has the tendency to extremely lower the blood sugar level. So, the doctor may lower the dose of insulin. Glimisave MV3.3 Tablet 10’s may lower your thyroid-stimulating hormone (TSH), so an annual check-up of TSH is suggested.
Drug Interactions
Drug-Drug Interaction: Glimisave MV 3.3 Tablet 10’s may interact with insulin, high blood pressure-lowering pills (hydrochlorothiazide, amlodipine), water pills/diuretics (furosemide), heart failure-related medicines (digoxin), anti-hypertensive (metoprolol), steroids (prednisolone), thyroid hormones etc. So, tell your doctor if you are using these drugs before taking Glimisave MV 3.3 Tablet 10’s.
Drug-Food Interaction: Taking Glimisave MV3.3 Tablet 10’s with alcoholic beverages may increase the risk of a rare but serious and potentially life-threatening condition known as lactic acidosis (build-up of lactic acid in the blood) and hypoglycaemia.
Drug-Disease Interaction: Glimisave MV 3.3 Tablet 10’s should be avoided in patients with vitamin B12 deficiency, kidney problems, liver problems, cardiovascular disease (heart-related issues) and low blood sugar level (hypoglycaemia) as it may worsen the condition.
